Navigation Links
Ear infection- a new treatment

The study in this week’s British Medical Journal shows that bacteria with the ability to inhibit the growth of the pathogens responsible for ear infections can be used successfully and may help reduce the use of antibiotics.

Acute Otitis Media is one of the most common bacterial infections in young children, and is often treated// with large amounts of antibiotics. It is caused by the spread of Streptococcus pneumoniae and other bacteria from the throat into the middle ear cavity.

Swedish medical experts have successfully treated children with chronic ear infection – ironically by infecting them with bacteria.Naturally occurring bacteria, such as alpha steptococci,protect the body from such infections. However children who get a lot of ear infections have been found to have a lower than normal amount of this bacteria.

The research studied 130 children with recurrent Otitis Media. Firstly, all the children were treated with antibiotics for 10 days, then divided into two groups. One group was given a nasal spray containing live growth-inhibiting bacteria, the other given a placebo.

After three months followup, researchers found that 42 per cent of children given the bacteria spray had no recurrence of infection, compared with only 22 per cent of those given the placebo.The researchers recolonised the children with naturally occurring bacteria to help boost the bodies defence system.

The authors say that using alpha streptococci may help offset antibiotic resistance among children prone to this type of ear infection.Dr Henley Harrison who heads the Ear, Nose and Throat Department at Sydney Children's Hospital said it was a novel approach with impressive results.


'"/>




Page: 1

Related medicine news :

1. A new infection- hot tub lung
2. Thyroid hormone treatment hastens recovery after cardiac surgery
3. Feeding channel created by malaria parasite - a new target for malaria treatments
4. Now umbilical cord helps in stroke treatment.
5. Now AIDS treatment comes dirt-cheap
6. Breast cancer treatment to be determined by gene test
7. Hemopurifier may revolutionise AIDS treatment
8. New drug helps boost cancer treatment
9. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
10. Experimental treatment for Ebola Virus Shows promising results in mice
11. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... ... February 10, 2016 , ... LaserShip, a regional parcel carrier that services the ... Eastern Michigan last Friday in order to aid in the Flint water crisis. In ... a facility located in Clio, only 15 miles away from Flint. , “We have ...
(Date:2/10/2016)... ... February 10, 2016 , ... InDemand ... within Healthcare, recently partnered with Heart City Health Center to improve ... 23 years, Heart City Health Center has provided the Elkhart community with access ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... 10 ... Brand. There were three leading bottled water brand owners that topped the list as ... enhance connectivity and optimize conversion. The premier brand was Tibet 5100, a top notch ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... welcomes S.S. Nesbitt as the latest addition to its growing list of Partner ... locations throughout the Southeast, from Orlando to Huntsville and in between. , Harnessing ...
(Date:2/10/2016)... ... February 10, 2016 , ... Pediatric therapists are challenged to ... shows that the Goal Attainment Scale (GAS) captures 20% more change in outcomes ... more about the Goal Attainment Scale, Education Resources Inc. is offering a course ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... and PITTSBURGH, Feb. 10, 2016 Mylan N.V. (NASDAQ, ... quarter and year ended December 31, 2015. ... Full year adjusted total revenues of $9.45 billion, up ... year; GAAP total revenues of $9.43 billion. Excluding the ... markets specialty and branded generics business (the "EPD Business"), ...
(Date:2/10/2016)... , Feb. 10, 2016  Resolve Therapeutics, ... transformative new approaches to the treatment of lupus ... of a multiple ascending dose study in patients ... compound RSLV-132. --> ... placebo-controlled multiple ascending dose study of RSLV-132 in ...
(Date:2/10/2016)... , Feb. 10, 2016  Rich Pharmaceuticals, Inc. (OTC ... a 1-for-100 reverse split of its issued and outstanding ... trading on Thursday, February 11, 2016. The Company,s common ... CUSIP number 76303T308 and temporary ticker symbol "RCHAD". After ... under the ticker symbol (RCHA).  --> ...
Breaking Medicine Technology: